企業プロフィール
Virax Biolabs 株価・ニュース・カタリスト
- ティッカー:
- VRAX
- 取引所:
- NASDAQ
- セクター:
- MedTech
- 所在地:
- United Kingdom and listed in the U
株価パフォーマンス
2.81 USD (-1.75%)
終値
最終更新: 2026年8月17日
1.61M USD
時価総額
株価変動の要因
As of Aug 17, 2026, VRAX closed down 1.75% at $2.81. No new same-company headline was identified in the current news window.
企業概要
事業概要
Virax Biolabs is a diagnostics company focused on immune profiling and infectious-disease testing. Its business is centered on molecular and laboratory diagnostics rather than therapeutics.
所在地とセクター分類
Virax Biolabs is headquartered in the United Kingdom and listed in the U.S. market. It sits in diagnostics and medical devices rather than biotechnology.
ビジネスモデルの特徴
The company depends on product adoption, test utilization, and commercialization in a competitive diagnostics market. Investors watch market access, product rollout, and operating execution.
バイオ業界での位置付け
Virax occupies the diagnostics layer of the healthcare stack. It is not a biotech drug name, but it belongs to the broader testing infrastructure that supports care decisions.
今後のカタリスト
- Virax’s catalysts are infectious-disease and immune-profiling programs, plus any update that shows the platform can still create value. The next step matters because the company remains early.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。